P. Malchair

Pulmonary Infections with Nontuberculous Mycobacteria, Catalonia, Spain, 1994–2014

F. Alcaide, M. Benítez, I. Barrabeig, 2018, Emerging infectious diseases.

Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients

Q. Bassat, B. Clotet, A. Troxel, 2022, Nature Communications.

High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial

Q. Bassat, B. Clotet, S. Marfil, 2022, The Lancet Respiratory Medicine.

A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)

C. Tebé, M. Gasa, S. Videla, 2022, Trials.

Departments involved during the first episode of acute heart failure and subsequent emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort

A. Mebazaa, Ò. Miró, H. Bueno, 2019, European journal of heart failure.

Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial

X. Solanich, F. Llopis, J. Jacob, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Recommendations for the early diagnosis of suspected human immunodeficiency virus infection in the emergency department and the referral of patients for follow-up: a consensus statement of the Spanish Society of Emergency Medicine (SEMES).

Ò. Miró, G. Burillo-Putze, A. Curran, 2020, Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias.

Exceptional treatment of COVID-19 pneumonia with icatibant.

F. Llopis, J. Jacob, P. Malchair, 2022, Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias.

Hydroxychloroquine Myocardial Toxicity in a Patient with Systemic Lupus Erythematosus

J. Salazar-Mendiguchía, X. Corbella, M. Rubio-Rivas, 2015 .

Convalescent plasma for outpatients with early COVID-19

Q. Bassat, B. Clotet, N. van Geloven, 2021, medRxiv.

Bayesian Analysis of the ICAT·COVID Randomized Clinical Trial.

J. Villoria, P. Malchair, J. Giol, 2023, Clinical therapeutics.